Medtronic(US:MDT) ZACKSยท2025-04-23 22:55Company Performance - Medtronic's stock closed at $83.75, reflecting a +0.46% change, which underperformed compared to the S&P 500's gain of 1.67% [1] - Over the past month, Medtronic shares have decreased by 5.89%, which is less than the Medical sector's decline of 9.34% and the S&P 500's drop of 6.57% [1] Earnings Expectations - Medtronic is set to release its earnings report on May 21, 2025, with an expected EPS of $1.58, representing an 8.22% increase from the same quarter last year [2] - Revenue is forecasted to be $8.81 billion, indicating a growth of 2.57% compared to the prior year [2] Annual Estimates - For the annual period, the Zacks Consensus Estimates predict earnings of $5.46 per share and revenue of $33.48 billion, reflecting increases of +5% and +3.44% respectively from the previous year [3] Analyst Sentiment - Changes in analyst estimates are crucial as they often indicate the company's business health and profitability outlook [3] - The Zacks Rank system, which incorporates these estimate changes, currently ranks Medtronic at 3 (Hold) [5] Valuation Metrics - Medtronic's Forward P/E ratio stands at 15.28, slightly above the industry's Forward P/E of 15.18 [5] - The company has a PEG ratio of 2.1, compared to the Medical - Products industry's average PEG ratio of 2.07 [6] Industry Context - The Medical - Products industry, part of the Medical sector, has a Zacks Industry Rank of 184, placing it in the bottom 26% of over 250 industries [6] - The Zacks Industry Rank measures the strength of industry groups based on the average Zacks Rank of individual stocks [7]